METHODS: Studies from five databases investigating
the link between an endoscopic examination and transfusion-transmissible infections (hepatitis B virus, hepatitis C virus, human immunodeficiency virus infection, Treponema pallidum) were retained and assessed independently by two reviewers. The association between endoscopy and transfusiontransmissible infections was identified by conducting meta-analyses and calculating pooled effect measures (odds ratios and 95% confidence intervals). The Grading of Recommendations, Assessment, Development, and Evaluation methodology was used to assess the quality of evidence.
RESULTS:
We identified 7571 references and finally included 29 observational studies. A significant association between an endoscopic examination and hepatitis B virus infection (pooled odds ratio [OR], 2.21; 95% confidence interval [CI], 1.26-3.86; p 5 0.005) or hepatitis C virus infection (pooled OR 1.76, 95% CI, 1.45-2.14; p < 0.00001) was found. The level of evidence was considered as "very low" due to the type of study design (i.e., observational) and indirect study populations (i.e., no blood donor populations).
CONCLUSION: An endoscopic examination is associated with an increased hepatitis B virus or hepatitis C virus infection risk. Further high-quality trials are required to formulate stronger evidence-based recommendations on endoscopic examination as a blood donor deferral criterion.
T he safe transfusion of blood and blood products helps to save millions of lives every year. However, in many countries, demand far exceeds supply, and blood services face the constant challenge of making sufficient blood available while also ensuring its quality and safety. In 2016, more than 40 years after the first World Health Assembly resolution (WHA28.72) addressed the issue of blood safety, equitable access to safe blood and blood products, and the rational and safe use of blood transfusion, there are still major challenges throughout the world, and many patients who require transfusion do not have timely access to safe blood. 1 An important element in the development of voluntary blood donor eligibility criteria throughout the world has been the attention given to minimizing the risk to recipients of donated blood, primarily the risk of infection by transfusion-transmitted diseases, such as human immunodeficiency virus (HIV), hepatitis B virus (HBV), hepatitis C virus (HCV), and Treponema pallidum.
2 Therefore, it is routine to complete a donor medical questionnaire and a physical examination before every blood donation to identify the donor's history relative to current, known blood-safety risks. 3 One of the potential risks addressed in the donor medical questionnaire is whether the blood donor has a (recent) history of endoscopic procedures. Because of its reusable nature and close contact with the inner body, it is hypothesized that an endoscope can pose a threat to the blood supply by serving as a means of transmitting different viruses. 4, 5 A European Directive in 2004 demanded a deferral period of 6 months (or 4 months when a nucleic acid test for HCV has proved negative) for every person who undergoes a flexible endoscopic examination. 6 However, the scientific basis for this temporary deferral criterion is still unclear. As proposed by European blood directives, it is recommended to use an evidencebased approach for basing donor selection criteria on solid scientific evidence. 7 Therefore, the objective of this systematic review was to identify all available scientific evidence on the association between an endoscopic examination and the risk of infection by transfusion-transmittable diseases. We hypothesized that individuals who undergo an endoscopic examination have an increased risk of a transfusion-transmitted infection (TTI).
MATERIALS AND METHODS
We carried out a systematic literature review according to a predefined protocol. 8 We planned and reported the systematic review in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) checklist (Appendix S1, available as supporting information in the online version of this paper). Two reviewers independently performed the title and abstract screening followed by the full text assessment according to these inclusion and exclusion criteria. Disagreements were resolved by discussion or by consulting a third reviewer.
Data extraction and quality assessment
Data concerning study design, population characteristics, risk factor (i.e., endoscopic examination), outcome measures (markers of TTIs expressed as a risk ratio, odds ratio, or incidence ratio), and study quality were extracted independently by two reviewers. In case studies that reported both unadjusted and adjusted effect measures, only the adjusted effect measures were extracted. The methodological quality of included studies as well as the overall level of the body of evidence was assessed using the Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) approach. 10 
RESULTS

Study selection
The systematic literature search resulted in a total of 7571 citations, which were scrutinized independently by two reviewers. Figure 1 1998-2002,) and four (14%) were published greater than 20 years ago. The majority of included studies (76%) were conducted in the European region (n 5 11: France, n 5 6; Italy, n 5 3; Turkey, n 5 1; Poland, n 5 1) and in the Eastern Mediterranean region (n 5 11: Iran, n 5 5; Egypt, n 5 4; Saudi Arabia, n 5 1; Lebanon, n 5 1). Three studies were performed both in the South-East Asia region (South Korea, n 5 3) and in the Western Pacific region (n 5 3: China, n 5 2; Australia, n 5 1), only one study was performed in the region of the Americas (Brazil, n 5 1), and no studies were done in the African region. The type of endoscope was not explicitly described in 22 studies; whereas digestive endoscopy (n 5 4), gastrointestinal endoscopy (n 5 2), and perendoscopic biopsy (n 5 1) were used in seven studies. All articles described different TTIs as risk factors for an endoscopic examination. Eighteen articles focused on HCV infection, nine described HBV infection as a possible risk factor, and two investigated the risk factors for both HBV and HCV. No articles documented the association between an endoscopic examination and HIV or T. pallidum. Details on the characteristics of the included studies are provided in Table 1 .
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Association between endoscopic examination and HBV infection Case-control studies
A meta-analysis of nine case-control studies revealed a significant association between HBV infection and endoscopic examination (pooled OR, 2.21; 95% CI, 1.26-3.86; p 5 0.005), with a large amount of heterogeneity between trials (I 2 5 90%) (Fig. 2) . 17, 19, 20, 27, 35, 40, [45] [46] [47] When excluding the study by Jahangirnezhad and colleagues, heterogeneity (I 2 ) was reduced from 90 to 56%. Therefore, this study was excluded from the different subgroup analyses. A first subgroup analysis on the type of HBV infection measure indicated that this association was still present in the studies that did not explicitly define the HBV infection outcome (e.g., acute or chronic; pooled OR, 1.43; 95% CI, 1.03-1.98; p 5 0.03) or had a specific chronic HBV infection outcome (OR, 86; 95% CI, 31.16-237.36; p < 0.00001). However, one Italian study that explicitly investigated an "acute HBV infection" could not demonstrate this association (OR, 1.40; 95% CI, 0.90-2.18; p 5 0.14). Subgroup differences were significant (p < 0.00001) (Fig. S1 , available as supporting information in the online version of this paper). A second subgroup analysis compared studies (Fig. S4 , available as supporting information in the online version of this paper). In a final subgroup analysis, data from one European country (i.e., Italy) were compared with data from seven non-European 
Association between endoscopic examination and HCV infection
Case-control studies
A meta-analysis of 17 case-control studies showed a significant association between HCV infection and endoscopic examination (pooled OR, 1.76; 95% CI, 1.45-2.14; p < 0.00001) with a moderate amount of heterogeneity between trials (I 2 5 47%) (Fig. 3) . 16, 18, 21, 22, [24] [25] [26] [28] [29] [30] [31] [32] [33] [34] 36, 38, 41 The different subgroup analyses uniformly confirmed this association statistically but did not further reduce the heterogeneity (Figs. S6-S10, available as supporting information in the online version of this paper).
Cohort studies
One prospective Italian study in a cohort of patients who underwent endoscopy and a cohort of blood donors demonstrated that digestive endoscopy was not a major risk factor for the transmission of HCV (OR, 0.51; 95% CI, 0.03-8.67; p 5 0.64). 23 
Level of evidence
All included studies were observational and thus had an initial low quality level of evidence (according to the GRADE approach). The risk of bias for each included study is detailed in the right in Figs. 2 and 3 , and detailed information is provide in Table S1 (available as supporting information in the online version of this paper 547% for HCV studies), and most individual effect measures (ORs) were less than 1 (harmful effect), no downgrading for inconsistency was applied. Visual inspection might demonstrate publication bias (i.e., funnel plot asymmetry) (Figs. S11 and S12, available as supporting information in the online version of this paper). However, no evidence of publication bias was found based on the linear regression test of funnel plot asymmetry (p 5 0.09 for HBV studies; p 5 0.24 for HCV studies). Indirectness due to study population was addressed, because none of the studies (except three 16, 24, 46 ) included blood donor populations. Therefore, the strength of the body of evidence (for the association between endoscopic examination with HBV and with HCV infection) was downgraded from low to very low.
DISCUSSION
The current systematic review identified 29 observational studies that investigated the association between endoscopy and TTIs. We observed that an endoscopic examination was significantly associated with HBV and HCV infection (only in the case-control studies, and not in the cohort studies). No studies were identified that linked an endoscopic examination with HIV infection or with T. pallidum. The quality of the evidence can be considered as very low because of the study type (observational studies) and the indirect population (no blood donor populations).
Our systematic review can be considered as relevant in terms of policy and may be useful for practice. To date, two systematic reviews concerning specific endoscopic examination and TTIs have been published. First, Morris and coworkers conducted a systematic review in 2005 but restricted the research question to gastrointestinal endoscopy and blood-borne viruses. Those authors screened only three databases (MEDLINE, Embase, and The Cochrane Library) and limited their search to full English-language texts. In addition, they did not conduct a meta-analysis and included study designs of lower quality (i.e., case series and case reports). The group concluded that there is a low risk of HBV and HCV infection during gastrointestinal endoscopy. 48 Second, Spach and colleagues published a systematic review 24 years ago in which they identified English-language papers published between 1966 and 1992 about transmission of infection by flexible gastroendoscopy and bronchoscopy. Their results indicated that the most common sources of infection were Salmonella, Pseudomonas, and Mycobacterium species. Nevertheless, those data were based mainly on case reports and were rather outdated. [Color figure can be viewed at wileyonlinelibrary.com]
In contrast, for our systematic review, we used a rigorous process, including sensitive search strategies in five databases and comprehensive selection criteria (no restriction to English-language studies or specific endoscopic examinations), resulting in scientific evidence, judged independently by two reviewers, that could be generalized for all endoscopic examinations. Furthermore, the use of meta-analyses with appropriate subgroup analyses enabled quantification of the associations and led to increased statistical power and precision. Although subgroup differences were not significant, three important trends were observed to contextualize the body of evidence. First, the association between endoscopy and HBV infection was more pronounced when effect measures were adjusted for confounding factors (such as age, sex, and history of blood transfusion). Therefore, appropriate statistical analysis methodology is required to adjust for the effect of confounders to establish a clear link between exposure (i.e., endoscopy) and outcome (i.e., HBV/HCV infection). 50 Second, the link between endoscopy and HBV/HCV infection tended to be stronger in studies conducted in regions that had higher versus lower HBV/HCV prevalence. Despite this difference, it must be emphasized that the precautionary principle is an important pillar of developing donor-selection criteria. This principle states that, in the interest of public health, risk-management action should be taken even in the absence of certainty about risk, thus aiming for maximum safety. 51 Therefore, the precautionary principle justifies the (temporary) exclusion of donors who have undergone an endoscopic examination, independent of the HBV/HCV prevalence in a specific region (i.e., low risk vs. high risk). Third, the significant association between endoscopy and HBV infection, as observed in studies conducted before the European Directive (before 2004), could not be demonstrated in studies conducted after the European Directive (2004 and later). However, for HCV, a significant association was observed in both European and nonEuropean studies published both before and after 2004. This suggests that the European Directive, which introduced a deferral period for donors who underwent endoscopy, was not able to break the link between endoscopy and TTIs. Two important factors need to be considered when determining the link between an endoscopic examination and TTIs: the type of decontamination techniques and maintenance of the decontamination system. Effective decontamination will protect the patient from infection, and it can be assumed that decontamination techniques have improved over the past decades. However, our analysis revealed that the association was still present in the studies conducted in the last 10 to 15 years, which may be attributable to maintenance issues. Indeed, several studies reported that the risk of infection due to gastrointestinal endoscopic examination is low when routine procedures are correctly followed 48, 52 and that bad maintenance of the decontamination system (e.g., automated endoscope reprocessors) is a common reason for most ready-to-use endoscope contaminations. 53 It would be worthwhile to explore whether the association with TTIs is different when using flexible endoscopes (which have a higher risk of contamination, especially when using manual decontamination methods) compared with rigid endoscopes (which have no contamination risk, because they can be steam sterilized) or to conduct an analysis with stratification based on the decontamination techniques that were used. Unfortunately, none of the studies included here provided information on the type of endoscope or the decontamination techniques, precluding such an analysis. The major limitation of the current analysis is that we only retrieved data from observational studies in nonblood donor populations (very low quality of evidence). We included two types of observational studies: casecontrol studies and cohort studies. A case-control study compares individuals who have a specific outcome of interest (i.e., HBV/HCV infection; cases) with individuals from the same population source who do not have that outcome (controls) to examine the association between the HBV or HCV infection and prior exposure (i.e., endoscopic examination). In our review, we included 26 casecontrol studies that were not able to provide any data on comparisons before versus after endoscopic HBV or HCV infection, because this is a major limitation of this study type. A cohort study defines a group of individuals (the cohort) that is followed over time to examine associations between different interventions (i.e., endoscopic examination) and subsequent outcomes (i.e., HBV or HCV infection). The quality of cohort studies is considered higher than that of case-control studies, because this study type is able to detect new HBV or HCV infections after individuals undergo an endoscopic examination (or not). We included three cohort studies that were not able to show a significant association between HBV or HCV infection and an endoscopic examination. 23, 37, 42 However, we considered the results of those three studies as imprecise (due to a lack of data, 37 large variation in the results, 23, 42 or low numbers of events 37, 42 ) and the corresponding conclusion as indicating "no evidence of an association" rather than "evidence of an association." To improve the quality of evidence and formulate stronger evidence-based conclusions, well-conducted observational studies (preferably cohort studies) or experimental studies are needed. Only experimental studies (e.g., randomized controlled trials) could clarify whether a direct causal relationship between an endoscopic examination and TTIs is present. Nevertheless, the feasibility and ethics surrounding the set-up of a randomized controlled trial with a control group that receives no intervention is questionable. A potential alternative study design would be a noninferiority study. 54 In this type of study, a new experimental treatment (e.g., Endoscopic Examination A) will be compared with an active control treatment (e.g., Endoscopic Examination B) to demonstrate that it is not clinically worse with regard to a specified endpoint (e.g., TTIs). In light of the European Directive, a multi-country study in the blood donor population is recommended to increase generalizability of the results. A second limitation is that the majority of studies (26 of 29 studies) did not use proper criteria (clinical, biochemical, and serological) to distinguish acute from chronic hepatitis infections. For example, the diagnosis of acute hepatitis infection is based on the detection in serum or plasma of HCV/HBV RNA or anti-HCV immunoglobulin G and an elevation of alanine aminotransferase levels. However, none of these markers alone or in combination can be used to identify acute infection, because they may also be detectable during the chronic phase of infection. 54 Differentiating between acute and chronic infection might have an impact on the association with endoscopy, because our subgroup analysis (n 5 2 studies; Fig. S1 ) identified a stronger association (i.e., statistically significant) with patients who had chronic hepatitis. Finally, none of the studies provided detailed information on the type of endoscope that was used. After the European Directive of 2004 was formulated, 6 blood services in European countries uniformly applied the recommended temporary deferral (i.e., from 4 to 6 months) from blood donation after endoscopic examination. If we want to replace the current precautionary, principle-driven deferral policies by evidence-based deferral policies, we need more high-quality primary research studies to elucidate whether the length of the deferral period (i.e., 4 months for a flexible endoscopic examination procedure), as stated by the European Directive, is still valid.
CONCLUSION
Evidence of very low quality from a systematic review of 29 observational studies revealed that an endoscopic examination is associated with an increased risk of HBV/ HCV infection. Further high-quality trials are required to formulate stronger evidence-based recommendations on endoscopic examination as a blood donor deferral criterion.
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Appendix S1. PRISMA checklist. Appendix S2. Detailed information on the search strategies in the different databases. Fig. S1 . Study-specific ORs representing the association between an endoscopic examination and HBV infection in case-control studies: subgroup analysis (acute vs. chronic HBV infection). Each dot represents the OR of the respective study together with a 95% CI. The size of the box represents the weight of the study in the metaanalysis. Weights are from random-effects analysis. Fig. S2 . Study-specific ORs representing the association between an endoscopic examination and HBV infection in case-control studies: subgroup analysis (unadjusted vs. adjusted ORs). Each dot represents the OR of the respective study together with a 95% CI. The size of the box represents the weight of the study in the metaanalysis. Weights are from random-effects analysis. Fig. S3 . Study-specific ORs representing the association between an endoscopic examination and HBV infection in case-control studies: subgroup analysis (low-prevalence region vs. high-prevalence region). Each dot represents the OR of the respective study together with a 95% CI. The size of the box represents the weight of the study in the meta-analysis. Weights are from randomeffects analysis. Weights are from random-effects analysis. Fig. S5 . Study-specific ORs representing the association between an endoscopic examination and HBV infection in case-control studies: subgroup analysis (European countries vs. non-European countries). Each dot represents the OR of the respective study together with a 95% CI. The size of the box represents the weight of the study in the meta-analysis. Weights are from random-effects analysis. Fig. S6 . Study-specific ORs representing the association between an endoscopic examination and HCV infection in case-control studies: subgroup analysis (acute HCV infection vs. HCV infection). Each dot represents the OR of the respective study together with a 95% CI. The size of the box represents the weight of the study in the metaanalysis. Weights are from random-effects analysis. Fig. S7 . Study-specific ORs representing the association between an endoscopic examination and HCV infection in case-control studies: subgroup analysis (unadjusted vs. adjusted ORs). Each dot represents the OR of the respective study together with a 95% CI. The size of the box represents the weight of the study in the metaanalysis. Weights are from random-effects analysis. Fig. S8 . Study-specific ORs representing the association between an endoscopic examination and HCV infection in case-control studies: subgroup analysis (low-prevalence region vs. high-prevalence region). Each dot represents the OR of the respective study together with a 95% CI. The size of the box represents the weight of the study in the meta-analysis. Weights are from randomeffects analysis. Weights are from random-effects analysis. Fig. S10 . Study-specific ORs representing the association between an endoscopic examination and HCV infection in case-control studies: subgroup analysis (European countries vs. non-European countries). Each dot represents the OR of the respective study together with a 95% CI. The size of the box represents the weight of the study in the meta-analysis. Weights are from random-effects analysis. Fig. S11 . Funnel plot for HBV. Fig. S12 . Funnel plot for HCV. Table S1 . Details of the risk of bias assessment.
